The triple threat: Tackling cardio renal-metabolic disease in primary care (Clinical lunch chat on-demand)

38943 [Converted] - Module image-01

In this episode Dr Theron and Dr Bayat covers early detection, staging, screening, lifestyle change, and breakthrough therapies like SGLT-2 inhibitors and incretins.

Learning objectives:

  • Enabling HCPs to define, characterise and assess CKM Syndrome
  • What to do in implementing targeted screening and monitoring
  • Providing guidance on how to optimise lifestyle and pharmacological interventions in patients
  • How to integrate novel and established therapies
  • Link treatment to measurable outcomes
ATTENTIONKindly note that if you attended the live webinar and completed the questions after the event, you have already received 1 CPD point and will not be permitted to receive additional points for the on-demand video and questions. Should this occur, the HPCSA will only record 1 CPD point from the live webinar, invalidating any additional CPD points from this activity.Please note deNovo Medica ensures uploading of your CPD points to the HPCSA: please don't upload these yourself.

To access this module, please register or login: